COVID-19 Associated Bilateral Acute Iris Transillumination

Yagci, Betul Akbulut; Atas, Ferdane; Kaya, Mahmut; Arıkan, Gül

doi:10.1080/09273948.2021.1933073

Cited by 19 publications

(12 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…A case of bilateral acute iris transillumination associated with COVID-19 has been reported by Yagci et al . [ 11 ] In our series, one patient with NGAU being treated with topical steroids had developed bilateral non-transilluminating depigmentation of the iris and pigment dispersion in the anterior chamber with no raised IOP after 2 weeks. To our knowledge, this may be the first case of bilateral acute depigmentation of iris reported from India following COVID-19 infection.…”

Section: Discussionmentioning

confidence: 82%

An analysis of the clinical profile of patients with uveitis following COVID-19 infection

Ganesh

Mohanan-Earatt²

2022

Indian J Ophthalmol

View full text Add to dashboard Cite

Purpose: To describe the clinical profile of patients presenting with uveitis following COVID-19 infection at a tertiary care eye hospital in South India. Methods: In this retrospective chart review, all consecutive cases presenting with an acute episode of intraocular inflammation and a history of COVID-19 infection diagnosed within the preceding 6 weeks, between March 2020 and September 2021, were included. Data retrieved and analyzed included age, sex, laterality of uveitis, and site of inflammation. The diagnosis was categorized based on the SUN working group classification criteria for uveitis. Details regarding clinical features, investigations, ophthalmic treatment given, response to treatment, ocular complications, and status at last visit were also accessed. Statistical analysis of demographical data was done using Microsoft Excel 2019. Results: Twenty-one eyes of 13 patients were included in this hospital-based retrospective observational study. The study included six male and seven female patients. The mean age was 38 ± 16.8 years. Eight patients had bilateral involvement. Seven patients were diagnosed with anterior uveitis, three with intermediate uveitis, one with posterior uveitis, and two with panuveitis. All patients responded well to treatment and were doing well at their last visit. Two patients had complications that necessitated surgical treatment, following which they recovered good visual outcomes. Conclusion: With prompt diagnosis and appropriate management, all the patients with uveitis post-COVID-19 infection recovered with good visual outcomes. Thus, ophthalmologists must be aware of the possible uveitic manifestations following even uneventful COVID-19 infection.

show abstract

Section: Discussionmentioning

confidence: 82%

An analysis of the clinical profile of patients with uveitis following COVID-19 infection

Ganesh

Mohanan-Earatt²

2022

Indian J Ophthalmol

View full text Add to dashboard Cite

show abstract

“…1 In BADI, there is no transillumination defect, depigmentation is caused by the iris stroma, and episodes of increased IOP are more frequent. 3,6 In the first published case report of BAIT associated with COVID-19 in the literature, the patient had elevated IOPs but was controlled with medical therapy alone. 6 In this case report, there was no use of systemic fluoroquinolone, but the use of favipiravir was present.…”

Section: Discussionmentioning

confidence: 99%

Bilateral Acute Iris Transillumination and Elevated Intraocular Pressure After COVID-19 Infection

Sevim

Şener

Evereklioğlu

2023

Journal of Glaucoma

View full text Add to dashboard Cite

Bilateral acute iris transillumination (BAIT) is characterized by abundant pigment discharge into the anterior chamber. Atonic pupil and severe intraocular pressure (IOP) elevations may be observed. Generally, there is a viral upper respiratory tract infection or systemic fluoroquinolone usage before BAIT. Two cases with a recent history of coronavirus disease 2019 (COVID-19) presented with a complaint of decreased vision. Elevated IOP and iris transillumination defects were observed in both patients. Both patients were diagnosed with BAIT. Although elevated IOP was controlled with medical treatment in 1 patient, glaucoma surgery was performed in the other patient because it could not be controlled with medical treatment. As both patients received no systemic treatment for COVID-19, the pressure rise seems to be directly related to the viral infection alone through the inflammatory process. Atypical ocular presentations of COVID-19 should be kept in mind as it can have serious consequences.

show abstract

“…3,10,13,19,34 During the recent COVID-19 pandemic, a total of 19 cases of BADI and BAIT were reported, 18 cases from Turkey and 1 from India. 16,18,34,35 In the recent series of 16 patients from Turkey (12 with BAIT and 4 with BADI), the mean interval between the COVID-19 infection and onset of ocular symptoms was 2.5 weeks. 18 Nine patients were treated with oral moxifloxacin and 4 patients with other antibiotics.…”

Section: Etiopathogenesismentioning

confidence: 99%

“…Sectoral posterior iris bowing on anterior segment OCT has been reported, 14 but not confirmed by others. 13,15,16 Interestingly, pigment dispersion in the anterior vitreous is not seen and the fundus is typically normal. 12,13 However, a cotton-wool spot was reported in one case, and cystoid macular edema was reported in another case with a prolonged clinical course with recurrent episodes.…”

Section: Introductionmentioning

confidence: 99%

Bilateral Acute Depigmentation of Iris (BADI) and Bilateral Acute Iris Transillumination (BAIT)-An Update

Tuğal-Tutkun¹,

Altan²

2022

tjo

View full text Add to dashboard Cite

Clinical Features of BADI BADI was first described in 2006 by Tugal-Tutkun and Urgancioglu 1 in a series of 5 cases from Turkey. They described an acute episode of pigment discharge in the anterior chamber from the iris stroma, bilateral symmetrical diffuse or geographical areas of depigmentation and discoloration of the iris stroma, Krukenberg's spindles, and pigment deposition in the trabecular meshwork. In their subsequent series, Tugal-Tutkun et al. 3 described 26 new cases and long-term follow-up of 2 cases. Following these early publications, many cases have been reported from other countries. 4,5,6,7,8,9 BADI affects predominantly young females. It presents as a sudden-onset redness, ocular pain, tearing, and photophobia in both eyes simultaneously or within a few days of each other. Severe photophobia is the most prominent symptom. The patients usually maintain normal visual acuity. 1,3,4,5 Patients with BADI present with severe diffuse episcleral injection, more pronounced than ciliary injection. They do not have signs of intraocular inflammation, but they present with circulating pigment in the anterior chamber, which may

show abstract

COVID-19 Associated Bilateral Acute Iris Transillumination

Cited by 19 publications

References 9 publications

An analysis of the clinical profile of patients with uveitis following COVID-19 infection

An analysis of the clinical profile of patients with uveitis following COVID-19 infection

Bilateral Acute Iris Transillumination and Elevated Intraocular Pressure After COVID-19 Infection

Bilateral Acute Depigmentation of Iris (BADI) and Bilateral Acute Iris Transillumination (BAIT)-An Update

Contact Info

Product

Resources

About